Poplar Forest Capital’s AbbVie ABBV Stock Holding History

Poplar Forest Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$3.04M	Hold	14,513	–	–	0.54%	32
2024 Q4	$2.58M	Sell	14,513 -62	-0.4%	-$11.4K	0.47%	31
2024 Q3	$2.88M	Hold	14,575	–	–	0.39%	30
2024 Q2	$2.5M	Hold	14,575	–	–	0.35%	31
2024 Q1	$2.65M	Hold	14,575	–	–	0.36%	32
2023 Q4	$2.26M	Sell	14,575 -175	-1%	-$25.5K	0.33%	32
2023 Q3	$2.2M	Hold	14,750	–	–	0.26%	33
2023 Q2	$1.99M	Hold	14,750	–	–	0.26%	32
2023 Q1	$2.35M	Hold	14,750	–	–	0.28%	33
2022 Q4	$2.38M	Hold	14,750	–	–	0.29%	33
2022 Q3	$1.98M	Sell	14,750 -465	-3%	-$66.7K	0.25%	32
2022 Q2	$2.33M	Hold	15,215	–	–	0.27%	34
2022 Q1	$2.47M	Hold	15,215	–	–	0.26%	35
2021 Q4	$2.06M	Buy	15,215 +465	+3%	+$54.9K	0.22%	35
2021 Q3	$1.59M	Hold	14,750	–	–	0.16%	35
2021 Q2	$1.66M	Hold	14,750	–	–	0.16%	36
2021 Q1	$1.6M	Sell	14,750 -300	-2%	-$32.1K	0.16%	37
2020 Q4	$1.61M	Hold	15,050	–	–	0.19%	35
2020 Q3	$1.32M	Hold	15,050	–	–	0.16%	38
2020 Q2	$1.48M	Hold	15,050	–	–	0.17%	36
2020 Q1	$1.15M	Hold	15,050	–	–	0.16%	41
2019 Q4	$1.33M	Hold	15,050	–	–	0.12%	38
2019 Q3	$1.14M	Hold	15,050	–	–	0.09%	41
2019 Q2	$1.09M	Hold	15,050	–	–	0.08%	43
2019 Q1	$1.21M	Hold	15,050	–	–	0.08%	40
2018 Q4	$1.39M	Hold	15,050	–	–	0.1%	40
2018 Q3	$1.42M	Hold	15,050	–	–	0.11%	39
2018 Q2	$1.39M	Sell	15,050 -200	-1%	-$19.5K	0.12%	41
2018 Q1	$1.44M	Hold	15,250	–	–	0.12%	41
2017 Q4	$1.48M	Hold	15,250	–	–	0.12%	39
2017 Q3	$1.35M	Hold	15,250	–	–	0.12%	40
2017 Q2	$1.11M	Hold	15,250	–	–	0.1%	41
2017 Q1	$994K	Hold	15,250	–	–	0.08%	38
2016 Q4	$955K	Hold	15,250	–	–	0.08%	41
2016 Q3	$962K	Hold	15,250	–	–	0.08%	41
2016 Q2	$944K	Sell	15,250 -2,640	-15%	-$161K	0.09%	40
2016 Q1	$1.02M	Hold	17,890	–	–	0.09%	50
2015 Q4	$1.06M	Sell	17,890 -650	-4%	-$37.4K	0.09%	50
2015 Q3	$1.01M	Hold	18,540	–	–	0.09%	48
2015 Q2	$1.25M	Hold	18,540	–	–	0.09%	48
2015 Q1	$1.08M	Sell	18,540 -450	-2%	-$27.2K	0.08%	57
2014 Q4	$1.24M	Hold	18,990	–	–	0.1%	54
2014 Q3	$1.1M	Hold	18,990	–	–	0.1%	58
2014 Q2	$1.07M	Hold	18,990	–	–	0.11%	41
2014 Q1	$976K	Hold	18,990	–	–	0.1%	39
2013 Q4	$1M	Hold	18,990	–	–	0.13%	38
2013 Q3	$849K	Hold	18,990	–	–	0.11%	38
2013 Q2	$785K	Buy	+18,990	New	+$831K	0.11%	39

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Poplar Forest Capital's ABBV Position: Q1 2025 in Review

Poplar Forest Capital held its AbbVie (ABBV) position steady in Q1 2025 at 14,513 shares worth $3.04M. The position accounts for 0.54% of the portfolio, ranked #32.

Poplar Forest Capital first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

Poplar Forest Capital held 14,513 shares of AbbVie worth $3.04M as of Q1 2025.
Poplar Forest Capital left its AbbVie share count unchanged in Q1 2025.
AbbVie made up 0.54% of Poplar Forest Capital's portfolio in Q1 2025, its #32 holding.
Poplar Forest Capital first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Poplar Forest Capital's 13F filing for Q1 2025, filed 6 May 2025.